| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/10/2007 | US20070105883 Novel physiologically active substances pf127oa, b and c substances |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105818 Water solubility, bioavailability, oral administration; unit dosage |
| 05/10/2007 | US20070104796 Use of xenon with hypothermia for treating neonatal asphyxia |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104658 Preparing spray-dried particles having a tap density of less than about 0.4 g/cm3 and have a hydrophobic amino acid and a therapeutic, prophylactic or diagnostic agent; pulmonary delivery; respiratory disorders |
| 05/10/2007 | DE19681207B4 Therapeutische Verwendung von Rubidiumionen und Zubereitungen Therapeutic Use of rubidium and preparations |
| 05/10/2007 | CA2627546A1 3 -monosubstituted tropane derivatives as nociceptin receptor ligands |
| 05/10/2007 | CA2627423A1 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783126A2 N-oxides of N-phenyl-2-pyrimidine-amine derivatives |
| 05/09/2007 | EP1782809A1 Use of ligands of PPARGamma for inducing foetal lung maturity and the prevention of the respiratory-distress syndrome in premature infants |
| 05/09/2007 | EP1782808A1 Preventive or therapeutic agent for chronic inflammatory lung disease |
| 05/09/2007 | EP1781686A2 Vla-4 antagonists |
| 05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/09/2007 | EP1781607A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 05/09/2007 | EP1781323A1 Composition comprising a pulmonary surfactant and a tnf-derived peptide |
| 05/09/2007 | EP1781300A1 Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases |
| 05/09/2007 | EP1781298A1 Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
| 05/09/2007 | EP1781290A2 Anti-inflammatory agents |
| 05/09/2007 | EP1781271A1 Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases |
| 05/09/2007 | EP1781104A2 Muscarinic acetylcholine receptor antagonists |
| 05/09/2007 | EP1781103A2 Muscarinic acetylcholine receptor antagonists |
| 05/09/2007 | EP1551369A4 Combination therapy for treatment of fibrotic disorders |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1960993A 6,6-bicyclic substituted heterobicyclic protein kinase inhibitors |
| 05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
| 05/09/2007 | CN1960762A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960761A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960760A Combinations comprising antimuscarinic agents and corticosteroids |
| 05/09/2007 | CN1960759A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |
| 05/09/2007 | CN1958053A Method for preparing gel of relieving a cough |
| 05/09/2007 | CN1958045A Method for producing medicine for treating tracheitis |
| 05/09/2007 | CN1958044A Animal use compound medicament with effects of pungent-cool diaphoretic, and removing toxic heat, and preparation method |
| 05/09/2007 | CN1958043A Method for preparing gel for wean to pacify common cold in children |
| 05/09/2007 | CN1958033A Tiandongqing |
| 05/09/2007 | CN1958023A Animal use compound medicament with effects for invigorating qi, strengthening the superficial, dispelling wind-evil, and being sensible, and preparation method |
| 05/09/2007 | CN1958021A Animal use compound medicament with effects for removing toxic heat, and preparation method |
| 05/09/2007 | CN1958020A Animal use compound medicament with effects for removing toxic heat, dispelling wind, relieving exterior syndrome, and preparation method |
| 05/09/2007 | CN1958019A Method for preparing gel of treating wean cough |
| 05/09/2007 | CN1958018A Method for preparing gel of treating wean rhinitis |
| 05/09/2007 | CN1958015A Chinese traditional medicine to be taken orally for treating disease of asthma in cough type |
| 05/09/2007 | CN1958008A Animal use compound medicament with effects of removing toxic heat, and preparation method |
| 05/09/2007 | CN1957999A Composition of Chinese traditional medicine, preparation method, and quality control method |
| 05/09/2007 | CN1957998A Animal use compound medicament with effects of removing toxic heat, removing heat from the blood to stop bleeding, and preparation method |
| 05/09/2007 | CN1957994A Animal use compound medicament with effect for clearing away the heat-evil and expelling superficial evils, and preparation method |
| 05/09/2007 | CN1957986A Animal use compound medicament with effect for dispelling wind, relieving exterior syndrome and removing toxic heat, and preparation method |
| 05/09/2007 | CN1957985A Method for preparing gel of treating wind-heat type common cold |
| 05/09/2007 | CN1957984A Capsule bubbles in use for treating allergic rhinitis, and preparation method |
| 05/09/2007 | CN1957983A Method for preparing gel of treating common cold in children |
| 05/09/2007 | CN1957966A Method of preparing gel for clearing away the heat-evil and expelling superficial evils |
| 05/09/2007 | CN1957959A Medication for treating chronic pharyngitis, sensitivity, and preparation method |
| 05/09/2007 | CN1957955A Soft capsule of Chinese traditional medicine, preparation method, and quality control method |
| 05/09/2007 | CN1957952A Method for preparing wean quick acting gel for treating common cold |
| 05/09/2007 | CN1314813C 虫草多肽制品及其制备方法和应用 Cordyceps polypeptide products and its preparation method and application |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314451C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 05/09/2007 | CN1314447C Method for preparing medicine with proteinase inhibiting function and its detecting method |
| 05/09/2007 | CN1314434C Heat-clearing and detoxic medicine and its preparation method |
| 05/09/2007 | CN1314428C Preparing process of medicinal composition for treating acute and chronic bronchitis |
| 05/09/2007 | CN1314418C Medicine for clearing away lung-heat, eliminating phaegn, reliveing cough and asthma and its preparing method |
| 05/09/2007 | CN1314400C Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method |
| 05/09/2007 | CN1314399C Child metho kahuangmin effervescent granules and its making method |
| 05/09/2007 | CN1314387C Children cough and asthma treating Chinese traditional medicine and its preparation |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214688 Compounds |
| 05/08/2007 | US7214687 Quinuclidine derivatives and medicinal compositions containing the same |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214672 Preventives/remedies for inflammatory airway diseases |
| 05/08/2007 | US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/08/2007 | CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 05/08/2007 | CA2441804C Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049752A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | WO2006108556A3 Pharmaceutical aerosol composition |
| 05/03/2007 | WO2006094924A3 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
| 05/03/2007 | US20070099958 Protease inhibitors |
| 05/03/2007 | US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |